Dr. Bernardo Dell’Osso. Graduated in medicine and completed his residency in the University of Milan. Currently Assistant Professor of Psychiatry at the University of Milan and psychiatrist at the Fondazione IRCCS Cà Granda Ospedale Policlinico of Milan. In February 2014, he has been enabled as Associate Professor of Psychiatry. He has done research activity in the U.S. at the Columbia University (Director Prof H. Sackeim) and Mount Sinai School of Medicine (Director Prof E. Hollander) of New York and Stanford University (Director Prof TA. Ketter), where he is still collaborating, as scientific advisor, for the Bipolar Disorders Clinic. He was selected for participation at the ECNP Young Scientist (Nice 2006) and ECNP School of Psychopharmacology (Oxford, 2009). He received several awards from national (società italiana di psicopatologia “SOPSI”, Università degli Studi di Milano “UNIMI”, innovazione in psichiatria “INNOPSY”) and international (world federation societies of biological psychiatry “WFSBP”) scientific institutions, along with the Fellowship Award from the European College of Neuropsychopharmacology (ECNP, Istanbul) in 2009 and the Lilly Young Investigator Fellowship Award from the International Conference on Bipolar Disorders (ICBD, Miami) in 2013. He received investigational grants from the anxiety disorders research network (ADRN)-ECNP, the international college of obsessive compulsive and related disorders (ICOCS) and FP7 grant, Marie Curie Actions. His main clinical research interests comprise Bipolar Disorder, Obsessive Compulsive Disorder, Impulse Control Disorders and neuromodulation. He serves on the editorial board of different national and international peer-reviewed journals and he is author of more than 200 scientific publications including peer-reviewed manuscripts and book chapters, in the fields of mood and anxiety disorders, epigenetics, psychopharmacology and neuromodulation.
Michael Van Ameringen, MD, FRCPC, is a Professor in the Department of Psychiatry and Behavioural Neurosciences at McMaster University in Hamilton, Ontario, Canada. His research is focused on the psychopharmacology of Obsessive Compulsive Disorder (OCD), Obsessive Compulsive spectrum disorders Social Phobia, Generalized Anxiety Disorder, treatment resistance in OCD, Anxiety Disorders and comorbid Mood Disorders. Other research interests include the use of the internet for the assessment of Anxiety Disorders, the epidemiology of Post Traumatic Stress Disorder, the use of virtual reality in the treatment of anxiety disorders, and the relationship of Attention Deficit/Hyperactivity Disorder to Anxiety Disorders. He has been a member of the Steering Committee for the development of Canadian Anxiety Disorder Treatment Guidelines Initiative and is currently involved in writing an updated version. As well, he was a member of the World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders. He is a member of the Board of Directors and the Scientific Advisory Council of the Anxiety and Depression Association of America and is on the editorial board for the journal Depression and Anxiety. Dr. Van Ameringen has published widely in the area of OCD and Anxiety Disorders.